1
TÍTULO: Effects of CYP2C19 genetic polymorphism on the steady-state concentration of citalopram in patients with major depressive disorder
AUTORES: Zastrozhin, MS; Skryabin, VY; Petukhov, AE; Torrado, MV; Pankratenko, EP; Zastrozhina, AK; Grishina, EA; Ryzhikova, KA; Shipitsyn, VV; Bryun, EA; Sychev, DA;
PUBLICAÇÃO: 2021, FONTE: PHARMACOGENOMICS JOURNAL
INDEXADO EM: Scopus WOS
2
TÍTULO: Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder
AUTORES: Michael S Zastrozhin; Valentin Y Skryabin; Marco Torrado; Anastasiya Petrovna; Alexander S Sorokin; Elena A Grishina; Kristina A Ryzhikova; Inessa A Bedina; Oleg Z Buzik; Egor M Chumakov; Ludmila M Savchenko; Evgeny A Brun; Dmitry A Sychev;
PUBLICAÇÃO: 2020, FONTE: PHARMACOGENOMICS, VOLUME: 21, NÚMERO: 2
INDEXADO EM: Scopus WOS
3
TÍTULO: Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome
AUTORES: Valentin Yurievich Skryabin; Mikhail Zastrozhin; Marco Torrado; Elena Grishina; Kristina Ryzhikova; Valery Shipitsyn; Tatiana Galaktionova; Alexander Sorokin; Evgeny Bryun; Dmitry Sychev;
PUBLICAÇÃO: 2020, FONTE: HOSPITAL PHARMACY
INDEXADO EM: Scopus WOS